Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Timber Pharmaceuticals is a privately held biopharmaceutical company.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
HistoWiz provides automated histopathology for biomedical researchers.
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Vivo Capital has invested in 165 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Candid Therapeutics received $505.0M in a Undisclosed round. Vivo Capital's total known invested capital is $12.4B.
Vivo Capital's average investment size is $110.3M across its portfolio of 165 companies.
Recent Vivo Capital portfolio additions include Pasithea Therapeutics, 35Pharma, Timber Pharmaceuticals, Biohaven Pharmaceutical, Kinaset Therapeutics. These companies were founded in 2020 or later.